Mainstay Medical’s ReActiv8 achieves long term efficacy in clinical study
ReActiv8 Restorative Neurostimulation device is developed for the treatment of adults with intractable chronic low back pain (CLBP)…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
10 Jan 22
ReActiv8 Restorative Neurostimulation device is developed for the treatment of adults with intractable chronic low back pain (CLBP)…
02 Dec 21
HoneyNaps’ digital therapeutic platform includes an AI software to diagnose sleep diseases, a non-contact sleep analysis and coaching…
23 Nov 21
The new prescription digital therapeutic candidate is said to expand the company’s addiction franchise
19 Nov 21
Prelivia has already gained U.S. Food and Drug Administration 510 (k) Clearance to promote healthy blood circulation and…
18 Nov 21
The funding will be used by the firm to conduct a first-in-human (FIH) clinical trial with its non-invasive…
12 Nov 21
The partnership makes NatureQuant’s NatureScoreTM technology available to researchers through Ksana Health’s Effortless Assessment Research System (EARS), an…
19 Oct 21
To validate its device’s capability to detect early neurocognitive impairments, Altoida will assess its software and digital biomarker…
08 Sep 21
Mayo Clinic researchers developed a set of paradigms, or viewpoints, that simplify comparisons between effects of electrical stimulation…
27 Aug 21
The COMMAND study will assess the safety and efficacy of the Stentrode in six severely paralysed patients in…
24 Aug 21
Rilaxta VRx, which is Cynergi’s software, will be used in combination with other treatments provided at NeuPath, as…